| Paracetamol |
№ II - 13774/ 21.06.2011 |
Jectamol, Solution for infusion, 1000 mg/ 6.7 ml, mg, Pack: 3 |
Phos Pharma Ltd, Кипър |
Uni Pharma Kleon Tsetis pharmaceutical laboratories S.A., Greece |
7.63 |
1.53 |
9.16 |
7% |
0.53 |
8.16 |
1.63 |
9.79 |
20% |
1.53 |
9.69 |
1.94 |
11.63 |
|
НСР-2378/21.01.2014 |
24.03.2014 |
24.03.2014 |
Активен |
2590 |
| Paracetamol |
№ II - 13774/ 21.06.2011 |
Jectamol, Solution for infusion, 1000 mg/ 6.7 ml, mg, Pack: 3 |
Phos Pharma Ltd, Кипър |
Uni Pharma Kleon Tsetis pharmaceutical laboratories S.A., Greece |
8.63 |
1.73 |
10.36 |
7% |
0.6 |
9.23 |
1.85 |
11.08 |
20% |
1.73 |
10.96 |
2.19 |
13.15 |
|
КЦ-2838/05.10.2011 |
20.10.2011 |
20.10.2011 |
Неактивен |
2590 |
| Metformin and linagliptin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.54 |
13.11 |
78.65 |
4% |
2.62 |
68.16 |
13.63 |
81.79 |
16% |
10.49 |
78.65 |
15.73 |
94.38 |
|
НСР-2887/05.03.2014; НСР-9112/27.04.2016 |
02.06.2016 |
02.06.2016 |
Активен |
2596 |
| Metformin and linagliptin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.62 |
13.12 |
78.74 |
4% |
2.62 |
68.24 |
13.65 |
81.89 |
16% |
10.5 |
78.74 |
15.75 |
94.49 |
|
НСР-2887/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2596 |
| Metformin and linagliptin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
69.82 |
13.96 |
83.78 |
4% |
2.79 |
72.61 |
14.52 |
87.13 |
16% |
11.17 |
83.78 |
16.76 |
100.54 |
|
HCР-150/13.06.2013 |
16.06.2013 |
16.06.2013 |
Неактивен |
2596 |
| Metformin and linagliptin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.54 |
13.11 |
78.65 |
4% |
2.62 |
68.16 |
13.63 |
81.79 |
16% |
10.49 |
78.65 |
15.73 |
94.38 |
|
НСР-2887/05.03.2014; НСР-9113/27.04.2016 |
02.06.2016 |
02.06.2016 |
Активен |
2595 |
| Metformin and linagliptin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.62 |
13.12 |
78.74 |
4% |
2.62 |
68.24 |
13.65 |
81.89 |
16% |
10.5 |
78.74 |
15.75 |
94.49 |
|
НСР-2887/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2595 |
| Metformin and linagliptin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
71.58 |
14.32 |
85.9 |
4% |
2.86 |
74.44 |
14.89 |
89.33 |
16% |
11.45 |
85.89 |
17.18 |
103.07 |
|
HCР-150/13.06.2013 |
16.06.2013 |
16.06.2013 |
Неактивен |
2595 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7080.67 |
1416.13 |
8496.8 |
4% |
10 |
7090.67 |
1418.13 |
8508.8 |
16% |
25 |
7115.67 |
1423.13 |
8538.8 |
|
НСР-7772/28.12.2015; НСР-10434/29.09.2016 |
02.11.2016 |
02.11.2016 |
Активен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7227.2 |
1445.44 |
8672.64 |
4% |
10 |
7237.2 |
1447.44 |
8684.64 |
16% |
25 |
7262.2 |
1452.44 |
8714.64 |
|
НСР-7772/28.12.2015 |
13.01.2016 |
13.01.2016 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7275.04 |
1455.01 |
8730.05 |
4% |
10 |
7285.04 |
1457.01 |
8742.05 |
16% |
25 |
7310.04 |
1462.01 |
8772.05 |
корекционно решение НСР-7663/01.12.2015 |
НСР-5979/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7498.65 |
1499.73 |
8998.38 |
4% |
10 |
7508.65 |
1501.73 |
9010.38 |
16% |
25 |
7533.65 |
1506.73 |
9040.38 |
|
НСР-2530/24.01.2014 |
19.02.2014 |
19.02.2014 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7766.6 |
1553.32 |
9319.92 |
4% |
10 |
7776.6 |
1555.32 |
9331.92 |
16% |
25 |
7801.6 |
1560.32 |
9361.92 |
|
КЦРР-2619/15.03.2013 |
03.04.2013 |
03.04.2013 |
Неактивен |
3727 |
| Povidone- iodine |
20120205 |
JODASEPT KUPRO 10%, Ointment, 10% - 90 g, -, Pack: 1 |
Купро 94 ООД, България |
Купро 94 ООД, гр. Горна Оряховица, България |
5.77 |
1.15 |
6.92 |
7% |
0.4 |
6.17 |
1.23 |
7.4 |
20% |
1.15 |
7.32 |
1.46 |
8.78 |
|
НСР-7869/15.01.2016 |
02.02.2016 |
02.02.2016 |
Активен |
4175 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 100, ml, Pack: 1 |
Купро 94 ООД, България |
Купро-94 ООД, Горна Оряховица |
2 |
0.4 |
2.4 |
7% |
0.14 |
2.14 |
0.43 |
2.57 |
20% |
0.4 |
2.54 |
0.51 |
3.05 |
корекционно решение НСР-9083/21.04.2016 |
НСР-8456/07.03.2016 |
02.04.2016 |
02.04.2016 |
Активен |
11508 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 100, ml, Pack: 1 |
Купро 94 ООД, България |
Купро-94 ООД, Горна Оряховица |
2 |
0.4 |
2.4 |
7% |
0.14 |
2.14 |
0.43 |
2.57 |
20% |
0.4 |
2.54 |
0.51 |
3.05 |
|
НСР-8456/07.03.2016 |
02.04.2016 |
02.04.2016 |
Неактивен |
11508 |
| Povidone- iodine |
20120206 |
JODASEPT KUPRO 10% (w/w), cutaneous solution, 1000, ml, Pack: 1 |
Купро 94 ООД, България |
Купро 94 ООД, гр. Горна Оряховица, България |
9.74 |
1.95 |
11.69 |
7% |
0.68 |
10.42 |
2.08 |
12.5 |
20% |
1.95 |
12.37 |
2.47 |
14.84 |
|
НСР-7868/15.01.2016 |
02.02.2016 |
02.02.2016 |
Активен |
4174 |
| Selegiline |
№ 121/ 09.12.2010 г. |
JUMEX, Tablet, 5, mg, Pack: 50 |
Санофи-Авентис България ЕООД, България |
Chinoin Private Co. Ltd., Veresegyhaz, Унгария |
11.42 |
2.28 |
13.7 |
6% |
0.69 |
12.11 |
2.42 |
14.53 |
18% |
2.06 |
14.17 |
2.83 |
17 |
промяна на обстоятелства НСР-4043/03.07.2014 |
НСР-71/07.06.2013 |
10.07.2013 |
10.07.2013 |
Активен |
1904 |
| Selegiline |
3465/13,11,2008 |
JUMEX, Tablet, 5, mg, Pack: 50 |
Санофи-Авентис България ЕООД, България |
Chinoin -Veresegyhaz - Унгария, Chinoin -Budapest - Унгария |
12.85 |
2.57 |
15.42 |
6% |
0.77 |
13.62 |
2.72 |
16.34 |
18% |
2.31 |
15.93 |
3.19 |
19.12 |
КЦ-920/26.05.2009 промяна на обстоятелства |
КЦ-470/29.01.2009 |
12.02.2009 |
12.02.2009 |
Неактивен |
1904 |
| Combinations |
20030099 |
Kabiven, Emulsion for infusion, 1540, ml, Pack: 1 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden; Frsenius Kabi Austria GmbH, Hafnerstrasse 36, 8055 Graz, Austria |
46.35 |
9.27 |
55.62 |
4% |
1.85 |
48.2 |
9.64 |
57.84 |
16% |
7.42 |
55.62 |
11.12 |
66.74 |
|
НСР-7269/ 21.10.2015.; НСР-9793/14.07.2016 |
02.08.2016 |
02.08.2016 |
Активен |
3044 |
| Combinations |
20030099 |
Kabiven, Emulsion for infusion, 1540, ml, Pack: 1 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden; Frsenius Kabi Austria GmbH, Hafnerstrasse 36, 8055 Graz, Austria |
48.23 |
9.65 |
57.88 |
4% |
1.93 |
50.16 |
10.03 |
60.19 |
16% |
7.72 |
57.88 |
11.58 |
69.46 |
|
НСР-7269/ 21.10.2015. |
05.11.2015 |
05.11.2015 |
Неактивен |
3044 |
| Combinations |
20030099 |
Kabiven, Emulsion for infusion, 1540, ml, Pack: 1 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden; Frsenius Kabi Austria GmbH, Hafnerstrasse 36, 8055 Graz, Austria |
49.27 |
9.85 |
59.12 |
4% |
1.97 |
51.24 |
10.25 |
61.49 |
16% |
7.88 |
59.12 |
11.82 |
70.94 |
|
НСР-4152/23.07.2014 |
07.08.2014 |
07.08.2014 |
Неактивен |
3044 |
| Combinations |
ІІ-6817/03.02.2003 г. |
Kabiven, Emulsion for infusion, 1540, ml, Pack: 1 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden; Frsenius Kabi Austria GmbH, Hafnerstrasse 36, 8055 Graz, Austria |
52.2 |
10.44 |
62.64 |
4% |
2.09 |
54.29 |
10.86 |
65.15 |
16% |
8.35 |
62.64 |
12.53 |
75.17 |
|
КЦРР-2675/20.03.2013 |
13.05.2013 |
13.05.2013 |
Неактивен |
3044 |
| Combinations |
ІІ-6817/03.02.2003 г. |
Kabiven, Emulsion for infusion, 1540, ml, Pack: 1 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden; Frsenius Kabi Austria GmbH, Hafnerstrasse 36, 8055 Graz, Austria |
57.87 |
11.57 |
69.44 |
4% |
2.31 |
60.18 |
12.04 |
72.22 |
16% |
9.26 |
69.44 |
13.89 |
83.33 |
|
КЦ-929/28.05.2009 |
11.06.2009 |
11.06.2009 |
Неактивен |
3044 |
| Combinations |
20030100 |
Kabiven Peripheral emulsion for intravenous infusion, Emulsion for infusion, 1440, ml, Pack: 1 |
Fresenius Kabi AB, Швеция |
Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden Frsenius Kabi Austria GmbH, Hafnerstrasse 36, 8055 Graz, Austria |
35.67 |
7.13 |
42.8 |
4% |
1.43 |
37.1 |
7.42 |
44.52 |
16% |
5.71 |
42.81 |
8.56 |
51.37 |
|
КЦРР-2739/20.03.2013 |
19.04.2013 |
19.04.2013 |
Активен |
1793 |